Author

A. J. Wiecek

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:differential expression· 3 Research Focus:gene regulatory network inference· 3 Organism:human· 3 Research Focus:cell-cell communication· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

M. Secrier· 3 shared D. H. Jacobson· 2 shared G. Malagoli Tagliazucchi· 2 shared A. R. Barr· 1 shared D. Kornai· 1 shared E. Withnell· 1 shared G. L. Bond· 1 shared L. E. Gourmet· 1 shared

Activity by Year

2021-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

M. Secrier

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer

A. J. Wiecek, S. J. Cutty, D. Kornai, M. Parreno-Centeno, L. E. Gourmet, G. Malagoli Tagliazucchi, D. H. Jacobson, P. Zhang, L. Xiong, G. L. Bond, A. R. Barr, M. Secrier

This study identifies genomic features of G0 cell cycle arrest in cancer and links it to therapy resistance using transcriptomic analysis and machine learning.

bioRxiv · Nov 12, 2021 · PreprintCancer Biology

Genomic and local microenvironment effects shaping epithelial-to-mesenchymal trajectories in cancer

G. Malagoli Tagliazucchi, A. J. Wiecek, E. Withnell, M. Secrier

The paper identifies three EMT macro-states in cancer tumors and shows their association with genomic features and microenvironment interactions.

bioRxiv · Jul 23, 2021 · PreprintCancer Biology

Pan-cancer survey of tumour mass dormancy and underlying mutational processes

A. J. Wiecek, D. H. Jacobson, W. Lason, M. Secrier

This study identifies immunological and angiogenic dormancy signals in 16.5% of cancers, links them to specific mutations and environmental factors, and associates dormancy with improved patient survival.

bioRxiv · Apr 25, 2021Cancer Biology